FDA Approves Xospata FDA Approves Xospata (gilteritinib) for Acute Myeloid Leukemia (AML) with a FLT3 Mutation November 28, 2018 -- The U.S. Food and Drug Administration today approved Xospata (gilteritinib) tablets for the treatment of adult patients w
FDA Approves Firdapse FDA Approves Firdapse (amifampridine) for Lambert-Eaton Myasthenic Syndrome November 28, 2018 -- The U.S. Food and Drug Administration today approved Firdapse (amifampridine) tablets for the treatment of Lambert-Eaton myasthenic sy
FDA Updates on Angiotensin II Receptor Blocker (ARB) Recalls